By Andy Smith
Social media is the new mainstream. A new report from Nielsen Co. finds that Americans are devoting almost a quarter of their Internet time on social networking sites and blogs, a 43 percent increase compared to one year ago. In the UK, social media has overtaken every other online activity.
Pharmaceutical companies still rely [...]
Entries Tagged as 'FDA'
Pixels & Pills Talks to Kevin Kruse about ePatient Connections 2010!
August 12th, 2010 · No Comments · News, Trends
Last year’s ePatient Connections conference was the event of the year, attracting some of the most influential voices in the industry and garnering lots of positive feedback from the attendees. Pixels & Pills sat down with conference leader Kevin Kruse to talk about why we all should be attending this year’s event.
1. ePatient Connections 2009 [...]
Tags:communication·Conferences·DDMAC·Digital Tools·drug safety·Education·epatient·events·Facebook·FDA·healthcare·interviews·marketing·Online Communities·patient communities·Patients·Pharma·social media·Social network·technology·Thought Leaders·Trends·Twitter·user needs·YouTube
Watching the Media: Avandia
July 27th, 2010 · No Comments · News, Opinion
Image courtesy of Present Diabetes
By Russ Ward (@russcward)
Over the last couple of weeks, if you haven’t heard people talking about Avandia, GlaxoSmithKline’s diabetes drug, you must have been on that mythical desert island that people always talk about.
The FDA convened a hearing to discuss the drug – and specifically, to discuss the heart attacks that [...]
Tags:advertising·Avandia·Blogs·cardiology·community·FDA·GlaxoSmithKline·live·marketing·media·Medicine·News·PR·press·public relations·restrictions·Twitter
Can Pharma Have an Old Spice Guy? Pharma’s Problems With Personality
July 16th, 2010 · 2 Comments · News, Opinion
By Kimberly Reyes (@CommDuCoeur)
It’s no shock that on Monday, February 8, 2010, people were buzzing about the Superbowl game the day before. What was a surprise is that they weren’t necessarily talking about the New Orleans Saints first Superbowl win against the Indianapolis Colts – they were most likely gushing over the Weiden + Kennedy [...]
Tags:Amgen·celebrity·endorsement·FDA·IPhone·John Mack·Johnson·Johnson & Johnson·marketing·Novo Nordisk·Old Spice·personality·Pharma·Pharmaceutical industry·social media·Twitter·VNR·Wyeth·YouTube
New Jobs in Pharma: Government Jobs
July 15th, 2010 · No Comments · Opinion
By Russ Ward (@russcward)
Contining our week on New Jobs in Pharma, we’ll talk today about government job opportunities.
When you talk about government jobs in pharma, most people might assume that you’re talking about working for the Food and Drug Administration. Well – the best answer there is “maybe”. First, because [...]
DTC: Death to Commercials
June 25th, 2010 · 4 Comments · Opinion
By Guy Mastrion (@gmastrion)
I’m going to speak heresy as an advertising creative director, specifically one working in healthcare. I’m coming to the belief that the FDA should put an end to branded TV commercials for pharma products.
Why?
Because I believe we’ve all been lulled into a healthcare coma by unimaginative, often nonsensical commercials attempting to communicate [...]
Tags:advertising·branding·commercials·communication·Compliance·creative·creativity·digital·DTC·FDA·marketing·Pharmaceutical industry·TV·Video
Pixels & Pills’ Ultimate Guide to Mobile Devices
May 27th, 2010 · 4 Comments · Knowledge
By Dan Bobear (@dbobear)
No, this is not a shopping guide. Go check out Engadget or Gizmodo if you want advice on the latest shiny things. We’ll wait.
…Back? Good. Because here, we’re not going to tell you about whether the iPad is worth buying or how to hack your new phone or what the latest Android [...]
Tags:Android·app·communication·doctors·FDA·iPad·IPhone·Mobile phone·Patients·Pharma
Interview with AstraZeneca’s Earl Whipple
May 17th, 2010 · 13 Comments · Uncategorized
Earl D. Whipple is the Senior Director of Business Communications and Digital Media for AstraZeneca. In an effort to drive online visibility and digital engagement for one of the world’s leading biopharmaceutical companies, Earl and his team launched AstraZeneca’s first company blog and Facebook community. Today, Pixels & Pills talks to Earl about Pharma’s obligation [...]
Tags:AstraZeneca·Blogs·corporate social responsibility·Earl Whipple·Education·Facebook·FDA·healthcare community·marketing·media·Pharma·Pharmaceutical industry·social media·technology·Thought Leaders·Trends
Following Up With Steve Woodruff of Impactiviti
May 14th, 2010 · No Comments · Opinion
This post wraps up our week-long discussion around the topic “What Would the Government Regulate?”
By Jason Brandt (@Jasondmg3)
Last month, Pixels & Pills’ Jennifer Abelson interviewed Steve Woodruff of Impactiviti at the ePharma Summit.
Apart from how utterly TV-presenter smooth both of their voices are – we’re lucky they got into pharma before they were snapped up [...]
Tags:advertising·communication·digital strategy·Facebook·FDA·innovation·Legal Issues·marketing·Pharmaceutical industry·regulations·social media·technology·Trends·Twitter
Healthcare Scares
May 10th, 2010 · No Comments · Opinion
This post continues our week-long theme of government regulation with a discussion on why it’s important for consumers to engage with with Pharma companies.
By Russ Ward (@russcward)
Every one of us has done it at least once.
You come down with some sickness, tally up the symptoms of your malady, and hit the internet. Ten minutes later, [...]
Tags:communication·Communities·Compliance·DTC·Education·FDA·Health care·Legal Issues·marketing·Patients·Pharma·social media·technology
